Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
Holding FBRX?
Track your performance easily

Forte Biosciences (FBRX) Income Statement

282 Followers

Forte Biosciences Income Statement

Last quarter (Q2 2024), Forte Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Forte Biosciences's net income was $-12.51M. See Forte Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 36.00K
Cost of Revenue
------
Gross Profit
-----$ 36.00K
Operating Expense
$ 37.22M$ 32.49M$ 13.90M$ 21.49M$ 46.28M$ 4.06M
Operating Income
$ -37.22M$ -32.49M$ -13.90M$ -21.49M$ -46.28M$ -4.06M
Net Non Operating Interest Income Expense
$ 1.12M$ 1.12M$ -162.00K--$ -2.26M
Other Income Expense
$ -1.04M$ -114.00K$ -145.00K$ 222.00K$ 205.00K$ 5.00K
Pretax Income
$ -35.61M$ -31.48M$ -13.88M$ -21.71M$ -46.53M$ -4.07M
Tax Provision
--$ -79.00K$ -67.00K$ -3.25M$ 1.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -35.76M$ -31.48M$ -13.88M$ -21.71M$ -46.49M$ -4.07M
Basic EPS
$ -0.69$ -1.00$ -20.00$ -38.75$ -158.00$ -67.25
Diluted EPS
$ -0.69$ -1.00$ -20.00$ -38.75$ -158.00$ -67.25
Basic Average Shares
$ 176.56M$ 31.48M$ 695.34K$ 558.71K$ 294.36K$ 945.22K
Diluted Average Shares
$ 176.56M$ 31.48M$ 695.34K$ 558.71K$ 294.36K$ 945.22K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 37.22M$ 32.49M$ 13.90M$ 21.49M$ 46.28M$ 4.06M
Net Income From Continuing And Discontinued Operation
$ -35.76M$ -31.48M$ -13.88M$ -21.71M$ -46.49M$ -4.07M
Normalized Income
$ -32.09M$ -24.87M-$ -21.71M$ -49.78M$ -3.21M
Interest Expense
------
EBIT
$ -36.53M$ -32.49M$ -13.90M$ -21.49M$ -14.22M$ -4.07M
EBITDA
$ -36.50M$ -32.48M$ -13.90M$ -21.45M$ -14.17M$ -4.06M
Currency in USD

Forte Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis